Nagai Taku, Noda Yukihiro, Ishikawa Kazuhiro, Miyamoto Yoshiaki, Yoshimura Masako, Ito Mina, Takayanagi Masanori, Takuma Kazuhiro, Yamada Kiyofumi, Nabeshima Toshitaka
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8560, Japan.
J Neurochem. 2005 Feb;92(3):660-7. doi: 10.1111/j.1471-4159.2004.02903.x.
In the central nervous system, tissue plasminogen activator (tPA) plays a role in synaptic plasticity and remodeling. Our recent study has suggested that tPA participates in the rewarding effects of morphine by regulating dopamine release. In this study, we investigated the role of tPA in methamphetamine (METH)-related reward and sensitization. Repeated METH treatment dose-dependently induced tPA mRNA expression in the frontal cortex, nucleus accumbens, striatum and hippocampus, whereas single METH treatment did not affect tPA mRNA expression in these brain areas. The METH-induced increase in tPA mRNA expression in the nucleus accumbens was completely inhibited by pre-treatment with R(+)-SCH23390 and raclopride, dopamine D1 and D2 receptor antagonists, respectively. In addition, repeated METH treatment increased tPA activity in the nucleus accumbens. There was no difference in METH-induced hyperlocomotion between wild-type and tPA-deficient (tPA-/-) mice. On the other hand, METH-induced conditioned place preference and behavioral sensitization after repeated METH treatment were significantly reduced in tPA-/- mice compared with wild-type mice. The defect of behavioral sensitization in tPA-/- mice was reversed by microinjections of exogenous tPA into the nucleus accumbens. Our findings suggest that tPA is involved in the rewarding effects as well as the sensitization of the locomotor-stimulating effect of METH.
在中枢神经系统中,组织型纤溶酶原激活剂(tPA)在突触可塑性和重塑过程中发挥作用。我们最近的研究表明,tPA通过调节多巴胺释放参与吗啡的奖赏效应。在本研究中,我们调查了tPA在甲基苯丙胺(METH)相关奖赏和敏化中的作用。重复给予METH可剂量依赖性地诱导额叶皮质、伏隔核、纹状体和海马体中tPA mRNA的表达,而单次给予METH对这些脑区中tPA mRNA的表达没有影响。分别用多巴胺D1受体拮抗剂R(+)-SCH23390和多巴胺D2受体拮抗剂雷氯必利预处理,可完全抑制METH诱导的伏隔核中tPA mRNA表达的增加。此外,重复给予METH可增加伏隔核中的tPA活性。野生型小鼠和tPA基因缺陷(tPA-/-)小鼠在METH诱导的运动亢进方面没有差异。另一方面,与野生型小鼠相比,tPA-/-小鼠在重复给予METH后,METH诱导的条件性位置偏爱和行为敏化显著降低。通过向伏隔核微量注射外源性tPA,可逆转tPA-/-小鼠行为敏化的缺陷。我们的研究结果表明,tPA参与了METH的奖赏效应以及运动刺激效应的敏化。